Liposomal Bupivacaine Doesnt Decrease Pain After
A study published in The Journal of Bone & Joint Surgery found that intraoperative use of liposomal bupivacaine does not improve pain scores or other outcomes for older adults undergoing hemiarthroplasty for hip fractures, compared to conventional bupivacaine. The randomized trial, conducted by researchers at Maimonides Medical Center, involved 50 older adults and assessed pain scores, opioid doses, and time to ambulate. Results showed no significant difference in pain scores or opioid requirements between the two groups. The study also highlighted the high cost of liposomal bupivacaine, which is 11 times more expensive than standard bupivacaine or other postoperative pain modalities. Researchers concluded that the use of liposomal bupivacaine in geriatric patients with hip fractures undergoing hemiarthroplasty warrants further questioning due to its increased costs. The study adds to the growing body of evidence that liposomal bupivacaine may not be beneficial in the context of primary total joint arthroplasty. Wolters Kluwer, the publisher of the study, provides clinical technology and solutions for various healthcare, tax, accounting, legal, and corporate compliance sectors.
Source: newswise.comPublished on 2024-09-19
Related news
- High rates of hip osteoarthritis among older adults with spinal deformity
- Rising rates of fractures around hip and knee repl
- Migraine surgery reduces headache days , reports Pl
- Robotic - assisted surgery and navigation dont affect infection risk after hip arthroplasty
- Early nerve intervention reduces pain and complications after amputation
- Primary Care Providers Urged to Assist Patients Wh
- Former Gilead Head of Legal Brett Pletcher Rejoins Gunderson Dettmer
- ChatGPT shows promise in answering patient quest
- Artificial Intelligence - Powered Drug Diversion Surveillance Now Part of Wolters Kluwer Sentri7 Suite – IT Business Net
- Rising rates of head and facial injuries from exercise and weightlifting
- Industry - Leading Fleet Safety Startup Netradyne Chooses 5WPR as Agency of Record
- Neural network enables objective assessment of breast symmetry
- Machine learning predicts which patients will cont
- Wolters Kluwer successfully prices €600 million five - year Eurobond
- Are Oil And Gas Lobbyists Influencing The COP Summits ?